注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Zealand Pharma A/S 是一家總部位於丹麥的生物技術公司。該公司專注於發現、設計和開髮用於代謝和胃腸道疾病以及其他未滿足醫療需求的罕見疾病領域的肽類藥物。該公司基於肽的候選產品包括臨床開發、註冊和潛在的商業化。其管道包括三個臨床開發中的候選產品:格列帕魯肽,正在開髮用於治療短腸綜合徵或短腸症候群;胰高血糖素配製用於雙激素人工胰腺系統,以更好地管理糖尿病;和胰高血糖素用於治療先天性高胰島素血症。該公司在丹麥和美國開展業務,擁有一系列藥物和候選產品,包括與勃林格殷格翰的合作。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Richard E. Pratley | - | 2011 | Member of Advisory Board |
Paul Dorian | - | 2011 | Member of Advisory Board |
Gudmund Tyge Korsgard | 67 | - | Board Observer |
Bernadette Mary Connaughton | 66 | 2019 | Independent Director |
Ake Lernmark | 79 | 2011 | Member of Advisory Board |
Bernard Charbonnel | - | 2011 | Member of Advisory Board |
Jeffrey Berkowitz | 58 | 2019 | Independent Director |
Gert Van Assche | - | 2011 | Member of Advisory Board |
Alf Gunnar Martin Nicklasson | 69 | 2014 | Independent Chairman of the Board |
Ludovic Otterbein | - | 2024 | Employee Representative |
Leonard Kruimer | 66 | 2019 | Independent Director |
Katja Hansen | - | 2024 | Alternate Director |
Adam Nygaard | - | 2024 | Employee Representative |
Cecilie Kold | - | - | Alternate Director |
Anneline Nansen | 55 | 2021 | Employee Representative Director |
Kirsten Aarup Drejer | 68 | 2018 | Independent Vice Chairman |
Elaine Sullivan | 63 | 2023 | Director & Member of Advisory Board |
Enrique A. Conterno Martinelli | 58 | 2023 | Member of Advisory Board & Director |
Lars Pedersen | - | 2024 | Alternate Director |
Tanja Erichsen | - | 2024 | Alternate Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核